The EMJ Podcast: Insights For Healthcare Professionals EMJ

Jonathan is joined by Joshua Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign, Stanford University, California, USA. The pair navigate fascinating themes, from Makower’s passion for music and his band, Still Trust, to innovative strategies for controlling rising healthcare costs through innovation. Makower offers perspectives on AI in healthcare, and the associated challenges with regulating these new technologies.
Use the following timestamps to navigate the topics discussed in this episode:
(00:00)-Introduction 

(03:05)-A passion for music 

(06:11)-From the Massachusetts Institute of Technology (MIT) to medical school 

(08:50)-The Biodesign process 

(19:37)-Driving technology from mind to marketplace 

(23:25)-Doctors engaging with industry 

(27:52)-The ExploraMed incubator 

(31:07)-Josh’s current work 

(34:27)-The importance of failure 

(36:16)-Perspectives on artificial intelligence in healthcare 

(39:05)-Healthcare innovation horizons 

(40:37)-Medical technology regulation 

(46:00)-Josh’s three wishes for the future of healthcare 

In this bonus episode of the EMJ podcast, host Sue Saville, a medical correspondent, discusses the latest advancements in access and hemostasis for coronary and other procedures via the distal radial route. Joined by Pavan Najran, clinical lead for interventional radiology and Consultant Clinical and Interventional Radiologist, The Christie Hospital NHS Foundation Trust, Manchester, UK, they further explore the benefits of the distal radial method, emphasizing reduced vascular complications, improved patient comfort, and shorter haemostasis time. Najran highlights the ergonomic advantages, dispels misconceptions, and shares insights from trials and personal experience, showcasing the potential for distal radial access to become the preferred approach.
Pavan Najran, is a clinical lead for interventional radiology and Consultant Clinical and Interventional Radiologist, The Christie Hospital NHS Foundation Trust, Manchester, UK.
The publication of this podcast was funded by Merit Medical. Dr Najran is a consultant to Merit Medicall.
The suggestions and other information, which may include both Merit and third-party products, are for the practitioner’s convenience and for general information purposes only. This information does not constitute medical or legal advice, nor is it meant to endorse or guarantee the suitability of any of the referenced products or methods for any specific patient or procedure. Before using, refer to the Instructions for Use (IFU) for indications, contraindications, warnings, precautions, and directions for use.

This podcast explores the fascinating world of artificial intelligence and advances on the horizon in oncology. Jonathan and Sofia Merajver, Michigan Medicine, Ann Arbor, USA, discuss vaccine hesitancy, the promise of artificial intelligence in generating large datasets, and non-small cell lung cancer, before concluding with her three wishes for healthcare.
 
Use the following tiestamps tot navigate the episode! 
(00:00)-Introduction
(00:46)-Breast cancer vaccine hesitancy
(07:38)-Advances on the horizon to prevent, protect, and treat malignancies
(09:30)-Hospitals in areas of conflict
(12:20)-Artificial intelligence
(17:28)-Non-small cell lung cancer
(23:10)-Sofia’s three wishes for healthcare

This podcast explores the genetic determinants and mechanisms of breast and ovarian cancer. Jonathan and Sofia Merajver, Michigan Medicine, Ann Arbor, USA, discuss brain metastases, the severity of inflammatory breast cancer, and the movement of cancers through tissue.
Use the following timestamps to navigate this episode!
(00:00)-Introduction
(02:27)-Sofia’s journey into medicine
(04:10)-Personal stakes
(05:09)-Not being your doctor
(06:58)-Genes in inflammatory breast cancer
(10:58)-RHO proteins
(12:52)-Brain metastasis
(17:33)-Crossing the blood–brain barrier
(22:11)-Aggressive phenotypes of breast cancer
(24:18)-Chemoprevention in breast cancer

This podcast explores the mOm Incubator, the importance of collaboration with healthcare professionals when designing medical devices, and the environmental impact of healthcare. Jonathan is joined by James Roberts, co-founder and CEO of mOm Incubators Ltd., a MedTech start-up on a mission to provide global access to high-quality healthcare. The pair discuss how the mOm incubator compares to traditional incubators, and the problems it solves.
 
Use the following timestamps to navigate this episode!
(00:00)-Introduction
(02:11)-Sparking interest in medical innovation
(04:11)-Navigating a medical device start-up
(07:03)-Unveiling the mOm incubator
(10:19)-The value of input from HCPs in device development
(13:04)-Delivering a simple yet low-risk device
(16:14)-Supplying mOm incubators to Ukraine
(20:16)-Considering the environmental impacts of medical devices
(23:30)-James’ proudest achievements
(26:58)-Looking to the future
(28:48)-Transport for London’s map of engineering icons
(31:09)-Three wishes for the future of healthcare

In this bonus episode of the EMJ podcast, Dr. Douglas Bradley is joining our host Dr Hannah Moir to discuss the recent outcomes from the ADVENT-HF randomised clinical trial. The discussion revolves around the relationship between heart failure and co-existing obstructive and/or central sleep apnoea. Dr Bradley considers the use of adaptive servo-ventilation (ASV), a non-invasive positive airway therapy, and provides insights on the trial outcomes. He also delves into the mechanism of action underlying ASV and discusses future developments in the sleep and cardiovascular space.
 
This podcast has been funded by Philips.